Primary |
Anaesthesia |
15.7% |
Drug Use For Unknown Indication |
15.6% |
Product Used For Unknown Indication |
14.3% |
Maintenance Of Anaesthesia |
11.6% |
Induction Of Anaesthesia |
11.4% |
General Anaesthesia |
8.6% |
Prophylaxis |
3.4% |
Premedication |
3.4% |
Induction And Maintenance Of Anaesthesia |
2.8% |
Neoplasm Malignant |
2.1% |
Analgesic Therapy |
1.5% |
Arrhythmia |
1.5% |
Laryngospasm |
1.5% |
Muscle Relaxant Therapy |
1.3% |
Surgery |
1.2% |
Sedation |
1.0% |
Hypotonia |
1.0% |
Blood Pressure Management |
0.8% |
Asthma |
0.7% |
Drug Exposure During Pregnancy |
0.7% |
|
Hyperthermia |
13.4% |
Rhabdomyolysis |
8.7% |
Unwanted Awareness During Anaesthesia |
8.7% |
Vomiting |
6.8% |
Pneumonia |
6.1% |
Electrocardiogram Qt Prolonged |
5.5% |
Anaesthetic Complication Neurological |
5.0% |
Torsade De Pointes |
4.8% |
Ventricular Tachycardia |
4.8% |
Ventricular Fibrillation |
4.5% |
Hypotension |
3.7% |
Nausea |
3.7% |
Cardiac Arrest |
3.5% |
Hyperthermia Malignant |
3.5% |
Pulmonary Oedema |
3.5% |
Staring |
3.4% |
Hypoxia |
2.9% |
Drug Exposure During Pregnancy |
2.6% |
Myocardial Infarction |
2.4% |
Oxygen Saturation Decreased |
2.4% |
|
Secondary |
Maintenance Of Anaesthesia |
17.2% |
Anaesthesia |
14.5% |
General Anaesthesia |
14.4% |
Product Used For Unknown Indication |
11.8% |
Induction Of Anaesthesia |
11.6% |
Drug Use For Unknown Indication |
5.6% |
Prophylaxis |
3.9% |
Premedication |
3.6% |
Induction And Maintenance Of Anaesthesia |
2.9% |
Arrhythmia |
1.8% |
Surgery |
1.8% |
Laryngospasm |
1.8% |
Neoplasm Malignant |
1.7% |
Analgesic Therapy |
1.2% |
Muscle Relaxant Therapy |
1.1% |
Anaesthesia Procedure |
1.1% |
Sedation |
1.0% |
Epidural Anaesthesia |
1.0% |
Hypertension |
1.0% |
Local Anaesthesia |
0.9% |
|
Low Birth Weight Baby |
22.8% |
Hyperthermia |
9.1% |
Unwanted Awareness During Anaesthesia |
8.7% |
Ventricular Tachycardia |
8.1% |
Delayed Recovery From Anaesthesia |
6.2% |
Pneumonia |
6.0% |
Ventricular Fibrillation |
4.7% |
Vomiting |
4.2% |
Rhabdomyolysis |
4.0% |
Torsade De Pointes |
3.9% |
Nausea |
3.7% |
Tachycardia |
2.9% |
Hypotension |
2.5% |
Stress Cardiomyopathy |
2.5% |
Hypoxia |
2.3% |
Cardiac Arrest |
2.0% |
Anaphylactic Shock |
1.8% |
Pulmonary Oedema |
1.7% |
Sinus Tachycardia |
1.5% |
Myotonia |
1.3% |
|
Concomitant |
Induction Of Anaesthesia |
17.4% |
Maintenance Of Anaesthesia |
13.8% |
Product Used For Unknown Indication |
13.3% |
Anaesthesia |
12.9% |
General Anaesthesia |
11.2% |
Drug Use For Unknown Indication |
8.0% |
Hypertension |
3.1% |
Epidural Anaesthesia |
2.5% |
Induction And Maintenance Of Anaesthesia |
2.1% |
Analgesic Therapy |
2.0% |
Postoperative Analgesia |
1.8% |
Anaesthesia Procedure |
1.8% |
Pain |
1.6% |
Neuromuscular Blockade Reversal |
1.5% |
Prophylaxis Of Nausea And Vomiting |
1.3% |
Local Anaesthesia |
1.2% |
Neuromuscular Blocking Therapy |
1.2% |
Prophylaxis |
1.2% |
Anaesthetic Premedication |
1.1% |
Hypotension |
1.1% |
|
Tachycardia |
9.4% |
Ventricular Tachycardia |
8.2% |
Pulmonary Oedema |
6.1% |
Tremor |
6.1% |
Respiratory Depression |
5.8% |
Respiratory Failure |
5.5% |
Anaphylactic Shock |
5.2% |
Unresponsive To Stimuli |
5.2% |
Cardiac Arrest |
4.8% |
Serotonin Syndrome |
4.8% |
Anaphylactic Reaction |
4.2% |
Drug Ineffective |
4.2% |
Drug Interaction |
4.2% |
Migraine |
3.9% |
Neuromuscular Block Prolonged |
3.9% |
Oxygen Saturation Decreased |
3.9% |
Pneumonia Aspiration |
3.9% |
Urticaria |
3.9% |
Renal Failure Acute |
3.3% |
Rhabdomyolysis |
3.3% |
|
Interacting |
General Anaesthesia |
34.3% |
Osteotomy |
10.2% |
Induction Of Anaesthesia |
8.3% |
Neuralgia |
5.9% |
Anaesthesia |
5.2% |
Hypertension |
5.2% |
Pain |
4.6% |
Maintenance Of Anaesthesia |
4.3% |
Varicose Vein Operation |
4.3% |
Product Used For Unknown Indication |
3.7% |
Tachycardia |
3.7% |
Musculoskeletal Pain |
2.8% |
Sedation |
1.9% |
Analgesia |
0.9% |
Blood Pressure Fluctuation |
0.9% |
Prophylaxis Of Nausea And Vomiting |
0.9% |
Thyroglossal Cyst Excision |
0.9% |
Analgesic Therapy |
0.6% |
Arginase Increased |
0.6% |
Arrhythmia |
0.6% |
|
Sinus Tachycardia |
40.9% |
Drug Interaction |
9.1% |
Cardiac Arrest |
6.8% |
Myotonia |
4.5% |
No Adverse Event |
4.5% |
Renal Failure Acute |
4.5% |
Supraventricular Extrasystoles |
4.5% |
Arrhythmia |
2.3% |
Hypotension |
2.3% |
Hypoxia |
2.3% |
Obstructive Airways Disorder |
2.3% |
Renal Tubular Necrosis |
2.3% |
Respiratory Depression |
2.3% |
Respiratory Paralysis |
2.3% |
Salivary Gland Neoplasm |
2.3% |
Tenotomy |
2.3% |
Ventricular Fibrillation |
2.3% |
Ventricular Tachycardia |
2.3% |
|